However, these results are controversial as both inhibitory and stimulatory functions have been reported for KIR2DL4, and it is unclear that HLA-G binds KIR2DL4 on NK cells in the tumor microenvironment2, 5. This evidence concerns the gene KIR2DL4 and neoplasm.